nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Myalgia—Docetaxel—ovarian cancer	0.000574	0.000574	CcSEcCtD
Dexmethylphenidate—Arthralgia—Docetaxel—ovarian cancer	0.000574	0.000574	CcSEcCtD
Dexmethylphenidate—Chest pain—Docetaxel—ovarian cancer	0.000574	0.000574	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Doxorubicin—ovarian cancer	0.000573	0.000573	CcSEcCtD
Dexmethylphenidate—Nausea—Vinorelbine—ovarian cancer	0.000573	0.000573	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Paclitaxel—ovarian cancer	0.000571	0.000571	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00057	0.00057	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Epirubicin—ovarian cancer	0.000565	0.000565	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Paclitaxel—ovarian cancer	0.000564	0.000564	CcSEcCtD
Dexmethylphenidate—Dry mouth—Docetaxel—ovarian cancer	0.000561	0.000561	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00056	0.00056	CcSEcCtD
Dexmethylphenidate—Fatigue—Paclitaxel—ovarian cancer	0.000559	0.000559	CcSEcCtD
Dexmethylphenidate—Sweating—Epirubicin—ovarian cancer	0.000557	0.000557	CcSEcCtD
Dexmethylphenidate—Pain—Paclitaxel—ovarian cancer	0.000555	0.000555	CcSEcCtD
Dexmethylphenidate—Constipation—Paclitaxel—ovarian cancer	0.000555	0.000555	CcSEcCtD
Dexmethylphenidate—Haematuria—Epirubicin—ovarian cancer	0.000554	0.000554	CcSEcCtD
Dexmethylphenidate—Confusional state—Docetaxel—ovarian cancer	0.000554	0.000554	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000551	0.000551	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00055	0.00055	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00055	0.00055	CcSEcCtD
Dexmethylphenidate—Oedema—Docetaxel—ovarian cancer	0.00055	0.00055	CcSEcCtD
Dexmethylphenidate—Weight increased—Doxorubicin—ovarian cancer	0.000549	0.000549	CcSEcCtD
Dexmethylphenidate—Epistaxis—Epirubicin—ovarian cancer	0.000548	0.000548	CcSEcCtD
Dexmethylphenidate—Infection—Docetaxel—ovarian cancer	0.000546	0.000546	CcSEcCtD
Dexmethylphenidate—Weight decreased—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Dexmethylphenidate—Sinusitis—Epirubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Dexmethylphenidate—Pneumonia—Doxorubicin—ovarian cancer	0.000541	0.000541	CcSEcCtD
Dexmethylphenidate—Shock—Docetaxel—ovarian cancer	0.000541	0.000541	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Docetaxel—ovarian cancer	0.000539	0.000539	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000538	0.000538	CcSEcCtD
Dexmethylphenidate—Infestation—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Dexmethylphenidate—Drowsiness—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Dexmethylphenidate—Tachycardia—Docetaxel—ovarian cancer	0.000537	0.000537	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000535	0.000535	CcSEcCtD
Dexmethylphenidate—Skin disorder—Docetaxel—ovarian cancer	0.000534	0.000534	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000533	0.000533	CcSEcCtD
Dexmethylphenidate—Bradycardia—Epirubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00053	0.00053	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Epirubicin—ovarian cancer	0.000525	0.000525	CcSEcCtD
Dexmethylphenidate—Anorexia—Docetaxel—ovarian cancer	0.000524	0.000524	CcSEcCtD
Dexmethylphenidate—Rhinitis—Epirubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Epirubicin—ovarian cancer	0.000522	0.000522	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Epirubicin—ovarian cancer	0.000518	0.000518	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—ovarian cancer	0.000516	0.000516	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Epirubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Dexmethylphenidate—Urticaria—Paclitaxel—ovarian cancer	0.000515	0.000515	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—ovarian cancer	0.000513	0.000513	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Epirubicin—ovarian cancer	0.000513	0.000513	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Paclitaxel—ovarian cancer	0.000513	0.000513	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Paclitaxel—ovarian cancer	0.000513	0.000513	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Epirubicin—ovarian cancer	0.000512	0.000512	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000509	0.000509	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—ovarian cancer	0.000507	0.000507	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—ovarian cancer	0.000505	0.000505	CcSEcCtD
Dexmethylphenidate—Visual impairment—Epirubicin—ovarian cancer	0.000503	0.000503	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000501	0.000501	CcSEcCtD
Dexmethylphenidate—Insomnia—Docetaxel—ovarian cancer	0.000497	0.000497	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Docetaxel—ovarian cancer	0.000494	0.000494	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Epirubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Docetaxel—ovarian cancer	0.00049	0.00049	CcSEcCtD
Dexmethylphenidate—Somnolence—Docetaxel—ovarian cancer	0.000489	0.000489	CcSEcCtD
Dexmethylphenidate—Eye disorder—Epirubicin—ovarian cancer	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—ovarian cancer	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Flushing—Epirubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Epirubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Docetaxel—ovarian cancer	0.000484	0.000484	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—ovarian cancer	0.000483	0.000483	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—ovarian cancer	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Docetaxel—ovarian cancer	0.000478	0.000478	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000478	0.000478	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000477	0.000477	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000475	0.000475	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000475	0.000475	CcSEcCtD
Dexmethylphenidate—Fatigue—Docetaxel—ovarian cancer	0.000474	0.000474	CcSEcCtD
Dexmethylphenidate—Angiopathy—Epirubicin—ovarian cancer	0.000474	0.000474	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—ovarian cancer	0.000473	0.000473	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Epirubicin—ovarian cancer	0.000471	0.000471	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00047	0.00047	CcSEcCtD
Dexmethylphenidate—Pain—Docetaxel—ovarian cancer	0.00047	0.00047	CcSEcCtD
Dexmethylphenidate—Constipation—Docetaxel—ovarian cancer	0.00047	0.00047	CcSEcCtD
Dexmethylphenidate—Chills—Epirubicin—ovarian cancer	0.000468	0.000468	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Epirubicin—ovarian cancer	0.000466	0.000466	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—ovarian cancer	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Asthenia—Paclitaxel—ovarian cancer	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Alopecia—Epirubicin—ovarian cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Pruritus—Paclitaxel—ovarian cancer	0.000459	0.000459	CcSEcCtD
Dexmethylphenidate—Mental disorder—Epirubicin—ovarian cancer	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Malnutrition—Epirubicin—ovarian cancer	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Erythema—Epirubicin—ovarian cancer	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Docetaxel—ovarian cancer	0.000453	0.000453	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—ovarian cancer	0.000451	0.000451	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00045	0.00045	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Tension—Epirubicin—ovarian cancer	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Paclitaxel—ovarian cancer	0.000444	0.000444	CcSEcCtD
Dexmethylphenidate—Nervousness—Epirubicin—ovarian cancer	0.000441	0.000441	CcSEcCtD
Dexmethylphenidate—Back pain—Epirubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—ovarian cancer	0.000438	0.000438	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Epirubicin—ovarian cancer	0.000437	0.000437	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—ovarian cancer	0.000436	0.000436	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000435	0.000435	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Docetaxel—ovarian cancer	0.000435	0.000435	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Docetaxel—ovarian cancer	0.000435	0.000435	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—ovarian cancer	0.000433	0.000433	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—ovarian cancer	0.000431	0.000431	CcSEcCtD
Dexmethylphenidate—Dizziness—Paclitaxel—ovarian cancer	0.000429	0.000429	CcSEcCtD
Dexmethylphenidate—Vision blurred—Epirubicin—ovarian cancer	0.000428	0.000428	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—ovarian cancer	0.000423	0.000423	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000422	0.000422	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—ovarian cancer	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—ovarian cancer	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Anaemia—Epirubicin—ovarian cancer	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Agitation—Epirubicin—ovarian cancer	0.000418	0.000418	CcSEcCtD
Dexmethylphenidate—Tension—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Dexmethylphenidate—Vomiting—Paclitaxel—ovarian cancer	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Malaise—Epirubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Dexmethylphenidate—Rash—Paclitaxel—ovarian cancer	0.000409	0.000409	CcSEcCtD
Dexmethylphenidate—Dermatitis—Paclitaxel—ovarian cancer	0.000409	0.000409	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—ovarian cancer	0.000408	0.000408	CcSEcCtD
Dexmethylphenidate—Vertigo—Epirubicin—ovarian cancer	0.000408	0.000408	CcSEcCtD
Dexmethylphenidate—Syncope—Epirubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Leukopenia—Epirubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Headache—Paclitaxel—ovarian cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Docetaxel—ovarian cancer	0.000405	0.000405	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—ovarian cancer	0.000404	0.000404	CcSEcCtD
Dexmethylphenidate—Palpitations—Epirubicin—ovarian cancer	0.000402	0.000402	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Epirubicin—ovarian cancer	0.000399	0.000399	CcSEcCtD
Dexmethylphenidate—Cough—Epirubicin—ovarian cancer	0.000397	0.000397	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—ovarian cancer	0.000396	0.000396	CcSEcCtD
Dexmethylphenidate—Asthenia—Docetaxel—ovarian cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Convulsion—Epirubicin—ovarian cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Hypertension—Epirubicin—ovarian cancer	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00039	0.00039	CcSEcCtD
Dexmethylphenidate—Pruritus—Docetaxel—ovarian cancer	0.000389	0.000389	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—ovarian cancer	0.000389	0.000389	CcSEcCtD
Dexmethylphenidate—Myalgia—Epirubicin—ovarian cancer	0.000387	0.000387	CcSEcCtD
Dexmethylphenidate—Arthralgia—Epirubicin—ovarian cancer	0.000387	0.000387	CcSEcCtD
Dexmethylphenidate—Chest pain—Epirubicin—ovarian cancer	0.000387	0.000387	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—ovarian cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Anxiety—Epirubicin—ovarian cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Nausea—Paclitaxel—ovarian cancer	0.000385	0.000385	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000384	0.000384	CcSEcCtD
Dexmethylphenidate—Discomfort—Epirubicin—ovarian cancer	0.000382	0.000382	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Dexmethylphenidate—Dry mouth—Epirubicin—ovarian cancer	0.000378	0.000378	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—ovarian cancer	0.000378	0.000378	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—ovarian cancer	0.000376	0.000376	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Docetaxel—ovarian cancer	0.000376	0.000376	CcSEcCtD
Dexmethylphenidate—Confusional state—Epirubicin—ovarian cancer	0.000374	0.000374	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—ovarian cancer	0.000372	0.000372	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000371	0.000371	CcSEcCtD
Dexmethylphenidate—Oedema—Epirubicin—ovarian cancer	0.000371	0.000371	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—ovarian cancer	0.00037	0.00037	CcSEcCtD
Dexmethylphenidate—Infection—Epirubicin—ovarian cancer	0.000368	0.000368	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—ovarian cancer	0.000367	0.000367	CcSEcCtD
Dexmethylphenidate—Shock—Epirubicin—ovarian cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Epirubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Dizziness—Docetaxel—ovarian cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Epirubicin—ovarian cancer	0.000363	0.000363	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—ovarian cancer	0.000363	0.000363	CcSEcCtD
Dexmethylphenidate—Tachycardia—Epirubicin—ovarian cancer	0.000362	0.000362	CcSEcCtD
Dexmethylphenidate—Skin disorder—Epirubicin—ovarian cancer	0.00036	0.00036	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000359	0.000359	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—ovarian cancer	0.000358	0.000358	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—ovarian cancer	0.000358	0.000358	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—ovarian cancer	0.000358	0.000358	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—ovarian cancer	0.000357	0.000357	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000355	0.000355	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—ovarian cancer	0.000354	0.000354	CcSEcCtD
Dexmethylphenidate—Anorexia—Epirubicin—ovarian cancer	0.000353	0.000353	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—ovarian cancer	0.00035	0.00035	CcSEcCtD
Dexmethylphenidate—Vomiting—Docetaxel—ovarian cancer	0.00035	0.00035	CcSEcCtD
Dexmethylphenidate—Rash—Docetaxel—ovarian cancer	0.000347	0.000347	CcSEcCtD
Dexmethylphenidate—Dermatitis—Docetaxel—ovarian cancer	0.000346	0.000346	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—ovarian cancer	0.000346	0.000346	CcSEcCtD
Dexmethylphenidate—Headache—Docetaxel—ovarian cancer	0.000344	0.000344	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000343	0.000343	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—ovarian cancer	0.000343	0.000343	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—ovarian cancer	0.000341	0.000341	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000338	0.000338	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—ovarian cancer	0.000338	0.000338	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000336	0.000336	CcSEcCtD
Dexmethylphenidate—Insomnia—Epirubicin—ovarian cancer	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—ovarian cancer	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—ovarian cancer	0.000333	0.000333	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Epirubicin—ovarian cancer	0.000333	0.000333	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000332	0.000332	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Epirubicin—ovarian cancer	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Somnolence—Epirubicin—ovarian cancer	0.00033	0.00033	CcSEcCtD
Dexmethylphenidate—Anorexia—Doxorubicin—ovarian cancer	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Nausea—Docetaxel—ovarian cancer	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Epirubicin—ovarian cancer	0.000326	0.000326	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Epirubicin—ovarian cancer	0.000322	0.000322	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00032	0.00032	CcSEcCtD
Dexmethylphenidate—Fatigue—Epirubicin—ovarian cancer	0.00032	0.00032	CcSEcCtD
Dexmethylphenidate—Pain—Epirubicin—ovarian cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Constipation—Epirubicin—ovarian cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000313	0.000313	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—ovarian cancer	0.00031	0.00031	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Doxorubicin—ovarian cancer	0.000308	0.000308	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—ovarian cancer	0.000306	0.000306	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Epirubicin—ovarian cancer	0.000306	0.000306	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—ovarian cancer	0.000305	0.000305	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000303	0.000303	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—ovarian cancer	0.000302	0.000302	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000296	0.000296	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—ovarian cancer	0.000296	0.000296	CcSEcCtD
Dexmethylphenidate—Urticaria—Epirubicin—ovarian cancer	0.000295	0.000295	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—ovarian cancer	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—ovarian cancer	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Epirubicin—ovarian cancer	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Epirubicin—ovarian cancer	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000283	0.000283	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000281	0.000281	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Epirubicin—ovarian cancer	0.000273	0.000273	CcSEcCtD
Dexmethylphenidate—Urticaria—Doxorubicin—ovarian cancer	0.000273	0.000273	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—ovarian cancer	0.000271	0.000271	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—ovarian cancer	0.000271	0.000271	CcSEcCtD
Dexmethylphenidate—Asthenia—Epirubicin—ovarian cancer	0.000266	0.000266	CcSEcCtD
Dexmethylphenidate—Pruritus—Epirubicin—ovarian cancer	0.000262	0.000262	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Epirubicin—ovarian cancer	0.000254	0.000254	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000253	0.000253	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—ovarian cancer	0.000246	0.000246	CcSEcCtD
Dexmethylphenidate—Dizziness—Epirubicin—ovarian cancer	0.000245	0.000245	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—ovarian cancer	0.000243	0.000243	CcSEcCtD
Dexmethylphenidate—Vomiting—Epirubicin—ovarian cancer	0.000236	0.000236	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—ovarian cancer	0.000235	0.000235	CcSEcCtD
Dexmethylphenidate—Rash—Epirubicin—ovarian cancer	0.000234	0.000234	CcSEcCtD
Dexmethylphenidate—Dermatitis—Epirubicin—ovarian cancer	0.000234	0.000234	CcSEcCtD
Dexmethylphenidate—Headache—Epirubicin—ovarian cancer	0.000232	0.000232	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—ovarian cancer	0.000227	0.000227	CcSEcCtD
Dexmethylphenidate—Nausea—Epirubicin—ovarian cancer	0.00022	0.00022	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—ovarian cancer	0.000218	0.000218	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—ovarian cancer	0.000216	0.000216	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—ovarian cancer	0.000216	0.000216	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—ovarian cancer	0.000215	0.000215	CcSEcCtD
Dexmethylphenidate—Nausea—Doxorubicin—ovarian cancer	0.000204	0.000204	CcSEcCtD
